How AI is Accelerating Clinical Decision-Making from Protocol Design Through Study Startup

Manual feasibility assessments, disconnected data handoffs, and siloed teams do not just delay study startup, they can trigger costly protocol amendments and put enrollment targets at risk. To move at the speed modern medicine demands, clinical operations teams need reliable intelligence embedded into existing workflows, supported by strong data, governance, and regulatory oversight. | Manual feasibility assessments, disconnected data handoffs, and siloed teams do not just delay study startup, they can trigger costly protocol amendments and put enrollment targets at risk.

Raccontata dafiercepharma.com